43.92
-1.06 (-2.35%)
| Penutupan Terdahulu | 44.97 |
| Jumlah Dagangan | 75,933 |
| Harga / Pendapatan (P/E Ke hadapan) | 9.82 |
| Harga / Jualan (P/S) | 1.84 |
| Harga / Buku (P/B) | 1.10 |
| Julat 52 Minggu |
| Margin Keuntungan | 18.86% |
| Margin Operasi (TTM) | 34.03% |
| EPS Cair (TTM) | 4.29 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 7.10% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 1.40% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 56.91% |
| Nisbah Semasa (MRQ) | 4.20 |
| Aliran Tunai Operasi (OCF TTM) | 251.52 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 188.69 M |
| Pulangan Atas Aset (ROA TTM) | 6.50% |
| Pulangan Atas Ekuiti (ROE TTM) | 12.30% |
AISkor Stockmoo
| Nilai 38% | -1.8 |
| AI Insight info | NA |
| Penilaian Relatif info | -5.0 |
| Kesihatan Kewangan info | 3.0 |
| Masa 38% | -1.1 |
| AI Technical info | NA |
| Osilator Teknikal info | -2.5 |
| Purata Bergerak Teknikal info | 1.0 |
| Sentimen 25% | 0.0 |
| Konsensus Penganalisis info | 0.0 |
| Sentimen Berita info | NA |
| Wang Pintar | NA |
| Aktiviti Orang Dalam info | NA |
| Aliran Institusi info | NA |
| Persekitaran | ×1.15 |
| Persekitaran Makro info | -3.3 |
| Sektor berbanding Pasaran (6B) | -4.0% |
| Persetujuan Tonggak | ×1.25 |
| Tidak dikira dalam skor | |
| Volatiliti Harga info | 1.8 |
| Skor Akhir | -1.57 |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Bercampur | Bercampur |
| Drug Manufacturers - Specialty & Generic (Global) | Bercampur | Bercampur | |
| Stok | Prestige Consumer Healthcare In | Bercampur | Menurun |
Saham Serupa
| Stok | Modal Pasaran | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| PBH | - | - | - | 1.10 |
| BHC | - | - | - | - |
| PRGO | - | 5.36% | - | 0.900 |
| EBS | - | - | - | 0.970 |
| RDY | - | 0.68% | - | 3.07 |
| TAK | - | 4.61% | - | 1.43 |
|
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige’s key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer’s Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 1.23% |
| % Dimiliki oleh Institusi | 108.15% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |